<DOC>
	<DOC>NCT01040624</DOC>
	<brief_summary>The purpose of this study is to see what effects, good and/or bad, proton based radiation combined with low dose chemotherapy and hormonal therapy, has on patients and their cancer.</brief_summary>
	<brief_title>Docetaxel, Androgen Deprivation and Proton Therapy for High Risk Prostate Cancer</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Docetaxel</mesh_term>
	<mesh_term>Androgens</mesh_term>
	<criteria>* Adenocarcinoma of the prostate. Previous prostate cancer treatment such as chemotherapy and/or pelvic radiation. Active inflammatory bowel disease (diverticulitis, Crohn's disease or ulcerative colitis) affecting the rectum. (Nonactive diverticulitis and Crohn's disease not affecting the rectum are allowed.) History of hip replacement. Prior intrapelvic surgery. This includes the following: Transrectal or rectal surgery other than polypectomy or hemorrhoid removal or banding Transabdominal pelvic surgery Bladder surgery Prior myocardial infarction (MI) or congestive heart failure (CHF). Taking Saw Palmetto or methotrexate and unable or unwilling to discontinue its use during radiation.</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>March 2017</verification_date>
	<keyword>Prostate Cancer, Proton Radiation</keyword>
</DOC>